IDEXX LABORATORIES INC /DE — Director's Dealing 2014

Feb 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-02-14

Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-14	Common Stock	M	2911	$34.37	Acquired	392576	Direct
2014-02-14	Common Stock	M	1080	—	Acquired	393656	Direct
2014-02-14	Common Stock	M	1200	—	Acquired	394856	Direct
2014-02-14	Common Stock	M	1200	—	Acquired	396056	Direct
2014-02-14	Common Stock	M	1600	—	Acquired	397656	Direct
2014-02-14	Common Stock	M	1600	—	Acquired	399256	Direct
2014-02-14	Common Stock	F	3330	$124.00	Disposed	395926	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-14	Incentive Stock Option (right to buy)	$34.37	M	2911	Disposed	2016-02-13	Common Stock (2911)	Direct
2014-02-14	Non-Qualified Stock Option (right to buy)	$124.00	A	44535	Acquired	2024-02-13	Common Stock (44535)	Direct
2014-02-14	Incentive Stock Option (right to buy)	$124.00	A	806	Acquired	2024-02-13	Common Stock (806)	Direct
2014-02-14	Restricted Stock Unit	$	A	4435	Acquired		Common Stock (4435)	Direct
2014-02-14	Restricted Stock Unit	$	M	1080	Disposed		Common Stock (1080)	Direct
2014-02-14	Restricted Stock Unit	$	M	1200	Disposed		Common Stock (1200)	Direct
2014-02-14	Restricted Stock Unit	$	M	1200	Disposed		Common Stock (1200)	Direct
2014-02-14	Restricted Stock Unit	$	M	1600	Disposed		Common Stock (1600)	Direct
2014-02-14	Restricted Stock Unit	$	M	1600	Disposed		Common Stock (1600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	49000	Indirect

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.

F2: Grant of options to buy shares of common stock becomes exercisable as to 9,069 shares on 02/14/2015, 9,068 shares on 02/14/2016, 02/14/2017 and 02/14/2018, and the remaining 8,262 shares on 02/14/2019.

F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2019) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F9: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.